 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Previous Article | Next Article
The Journal of Neuroscience, 0000, 20:RC87:1-5
RAPID COMMUNICATION
Fractalkine Cleavage from Neuronal Membranes Represents an Acute Event in the Inflammatory Response to Excitotoxic Brain DamageGayle A. Chapman1, Kitty Moores2, David Harrison1, Colin A. Campbell1, Brian R. Stewart1, and Paul J. L. M. Strijbos1 Departments of 1 Neuroscience Research and 2 Vascular Biology, SmithKline Beecham Pharmaceuticals, Harlow, Essex, CM19 5AW, United Kingdom
Fractalkine is a recently identified chemokine that exhibits cell adhesion and chemoattractive properties. It represents a unique member of the chemokine superfamily because it is located predominantly in the brain in which it is expressed constitutively on specific subsets of neurons. To elucidate the possible role of neuronally expressed fractalkine in the inflammatory response to neuronal injury, we have analyzed the regulation of fractalkine mRNA expression and protein cleavage under conditions of neurotoxicity. We observed that mRNA encoding fractalkine is unaffected by experimental ischemic stroke (permanent middle cerebral artery occlusion) in the rat. Similarly, in vitro, levels of fractalkine mRNA were unaffected by ensuing excitotoxicity. However, when analyzed at the protein level, we found that fractalkine is rapidly cleaved from cultured neurons in response to an excitotoxic stimulus. More specifically, fractalkine cleavage preceded actual neuronal death by 2-3 hr, and, when evaluated functionally, fractalkine represented the principal chemokine released from the neurons into the culture medium upon an excitotoxic stimulus to promote chemotaxis of primary microglial and monocytic cells. We further demonstrate that cleavage of neuron-derived, chemoattractive fractalkine can be prevented by inhibition of matrix metalloproteases. These data strongly suggest that dynamic proteolytic cleavage of fractalkine from neuronal membranes in response to a neurotoxic insult, and subsequent chemoattraction of reactive immune cells, may represent an early event in the inflammatory response to neuronal injury.
Key words: chemokines; fractalkine; chemotaxis; neuroinflammation; proteolytic cleavage; excitotoxicity; stroke
Copyright © 0000 Society for Neuroscience 0270-6474/00/$05.00/0
This article has been cited by other articles:
L. A. Truman, C. A. Ford, M. Pasikowska, J. D. Pound, S. J. Wilkinson, I. E. Dumitriu, L. Melville, L. A. Melrose, C. A. Ogden, R. Nibbs, et al.
CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis
Blood, December 15, 2008; 112(13): 5026 - 5036.
[Abstract] [Full Text] [PDF]
A. Szklarczyk, O. Ewaleifoh, J.-C. Beique, Y. Wang, D. Knorr, N. Haughey, T. Malpica, M. P. Mattson, R. Huganir, and K. Conant
MMP-7 cleaves the NR1 NMDA receptor subunit and modifies NMDA receptor function
FASEB J, November 1, 2008; 22(11): 3757 - 3767.
[Abstract] [Full Text] [PDF]
G. Murphy, N. Caplice, and M. Molloy
Fractalkine in rheumatoid arthritis: a review to date
Rheumatology, October 1, 2008; 47(10): 1446 - 1451.
[Abstract] [Full Text] [PDF]
C. Lauro, S. Di Angelantonio, R. Cipriani, F. Sobrero, L. Antonilli, V. Brusadin, D. Ragozzino, and C. Limatola
Activity of Adenosine Receptors Type 1 Is Required for CX3CL1-Mediated Neuroprotection and Neuromodulation in Hippocampal Neurons
J. Immunol., June 1, 2008; 180(11): 7590 - 7596.
[Abstract] [Full Text] [PDF]
J. M. Gee, A. Kalil, M. Thullbery, and K. J. Becker
Induction of Immunologic Tolerance to Myelin Basic Protein Prevents Central Nervous System Autoimmunity and Improves Outcome After Stroke
Stroke, May 1, 2008; 39(5): 1575 - 1582.
[Abstract] [Full Text] [PDF]
X. P. Yang, S. Mattagajasingh, S. Su, G. Chen, Z. Cai, K. Fox-Talbot, K. Irani, and L. C. Becker
Fractalkine Upregulates Intercellular Adhesion Molecule-1 in Endothelial Cells Through CX3CR1 and the Jak Stat5 Pathway
Circ. Res., November 9, 2007; 101(10): 1001 - 1008.
[Abstract] [Full Text] [PDF]
L. Struzynska, B. Dabrowska-Bouta, K. Koza, and G. Sulkowski
Inflammation-Like Glial Response in Lead-Exposed Immature Rat Brain
Toxicol. Sci., January 1, 2007; 95(1): 156 - 162.
[Abstract] [Full Text] [PDF]
C. Lauro, M. Catalano, F. Trettel, F. Mainiero, M. T. Ciotti, F. Eusebi, and C. Limatola
The Chemokine CX3CL1 Reduces Migration and Increases Adhesion of Neurons with Mechanisms Dependent on the beta1 Integrin Subunit
J. Immunol., December 1, 2006; 177(11): 7599 - 7606.
[Abstract] [Full Text] [PDF]
D. Ragozzino, S. Di Angelantonio, F. Trettel, C. Bertollini, L. Maggi, C. Gross, I. F. Charo, C. Limatola, and F. Eusebi
Chemokine Fractalkine/CX3CL1 Negatively Modulates Active Glutamatergic Synapses in Rat Hippocampal Neurons
J. Neurosci., October 11, 2006; 26(41): 10488 - 10498.
[Abstract] [Full Text] [PDF]
C. Sonnet, P. Lafuste, L. Arnold, M. Brigitte, F. Poron, F. Authier, F. Chretien, R. K. Gherardi, and B. Chazaud
Human macrophages rescue myoblasts and myotubes from apoptosis through a set of adhesion molecular systems
J. Cell Sci., June 15, 2006; 119(12): 2497 - 2507.
[Abstract] [Full Text] [PDF]
D. Huang, F.-D. Shi, S. Jung, G. C. Pien, J. Wang, T. P. Salazar-Mather, T. T. He, J. T. Weaver, H.-G. Ljunggren, C. A. Biron, et al.
The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system
FASEB J, May 1, 2006; 20(7): 896 - 905.
[Abstract] [Full Text] [PDF]
S. H. Ahmed, R. Lutjens, L. D. van der Stap, D. Lekic, V. Romano-Spica, M. Morales, G. F. Koob, V. Repunte-Canonigo, and P. P. Sanna
Gene expression evidence for remodeling of lateral hypothalamic circuitry in cocaine addiction
PNAS, August 9, 2005; 102(32): 11533 - 11538.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|